Innovation Ltd Panacea serves as Executive at Atara Biotherapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Innovation Ltd Panacea has executed 4 insider transactions totaling $1.2M, demonstrating a bullish approach to their equity position. Their most recent transaction on Jan 12, 2026 involved selling 80,554 shares valued at $489.0K.
Innovation Ltd Panacea currently holds 1,324,446 shares of Atara Biotherapeutics, Inc. (ATRA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Innovation Ltd Panacea has been a net buyer of ATRA stock. They have purchased $670.5K and sold $489.0K worth of shares.
Innovation Ltd Panacea's most recent insider trade was on Jan 12, 2026, when they sold 80,554 shares at $6.07 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Nov 28, 2025 | ATRA | $14 | Payment | 1 | $14.03 | Discretionary |
| Aug 15, 2025 | ATRA | $670.5K | Purchase | 55,000 | $12.19 | Discretionary |